Qinghai Lihao engages in the process technology research and development, production, sales and related supporting new energy business.
Aqronos specializes in advanced LiDAR technology designed for autonomous driving and driver assistance systems. The company focuses on enhancing vehicle safety by equipping them with sophisticated sensors that improve their vision capabilities. By transforming vehicles into intelligent guardians, Aqronos aims to create safer driving experiences for all road users.
Developer of application-specific integrated circuit (ASIC) designed for cloud networking. The company develops ASIC used for high speed packet switching, improving cloud networking technology.
Liansu Technology is a software company specializing in the development of high-performance graphics rendering GPUs. The company focuses on creating domestically-made GPU chips using self-developed architecture and proprietary intellectual property. Liansu aims to serve the expansive domestic market for rendering GPUs, which is valued at 200 billion, by delivering high-performance graphics rendering solutions across various platforms, including devices, cloud computing, and automotive applications. Its products cater to diverse industries such as gaming, digital twins, the metaverse, virtual and augmented reality, ultra-high-definition video, and professional design. By leveraging its advanced technology, Liansu Technology provides partners with comprehensive software and hardware solutions tailored to meet the evolving needs of the digital economy.
Erised Semiconductor is a circuit designer and manufacturer that provides users with display driver and power management chips. The applications can be found in radiofrequency applications, discrete devices, and other products.
Chipone Technology (Beijing) Co., Ltd. is an integrated circuit design company specializing in high-end power management and display-related integrated circuits in China. Established in 2008 and based in Beijing, the company develops a comprehensive range of products, including display driver chips, touch panel control sensors, and power management solutions. Its offerings encompass TDDI (display driver and touch integrated chips), OLED display chips, LED display driver chips, and timing control chips. Chipone serves a diverse clientele, including major global panel manufacturers and leading mobile phone brands, as well as prominent LED display manufacturers. The company also provides low power capacitive touch sensor controllers and advanced PWM DC-DC converters for various applications, including smartphones, tablets, and digital cameras. Chipone Technology sells its products online and supports its customers with additional services, bolstering its position as a competitive player in the display chip market.
Researcher and developer of pharmaceutical drugs. The company develops ophthalmic drugs, small molecule immune drugs, and cell therapies based on gene editing, providing innovative products to ophthalmology, medical beauty and pet medicine.
Svolt Energy Technology Co., Ltd. is a high-tech new energy company that specializes in energy technology, including electric vehicle battery (EVB) materials, cells, modules, PACK, BMS, energy storage system (ESS) and solar energy R&D and manufacturing. Headquartered in Wuxi, Jiangsu, SVOLT plans for 7 R&D centers around the globe, with four currently in operation, in Baoding, Korea, Shanghai and India, and three are under construction in the US, Japan and Wuxi. Domestically, SVOLT’s factory is under construction in Changzhou, Jiangsu, which will be operational by the end of 2019 with SOP in February 2020, and will have a capacity of 12GWh in 2020. Roadmap: SVOLT is pioneering the introduction of prismatic stacking batteries, making it the world’s first high-speed stacking prismatic battery maker. SVOLT aims to finish stacking one cell in 0.25 seconds in one single station. In contrast to the same type of winding process, the energy density of SVOLT stacking batteries improves 5%, the cycle life improves 10% and the cost reduces 15%.
Tongshu Gene is a high-tech enterprise specializing in tumor precision medicine. The company offers gene testing services and develops diagnostic molecular pathology projects, alongside ctDNA precision detection systems that utilize high-throughput gene sequencing technology and biological information analysis. These innovations enable clinicians to access consulting services related to precision medication, efficacy monitoring, postoperative recurrence tracking, as well as risk prediction and early detection of tumors.
Stemirna Therapeutics Co., Ltd. is a biotechnology company based in Shanghai, China, founded in 2016. The company specializes in developing mRNA technology-based drug solutions, with a focus on personalized cancer vaccines, mRNA vaccines for infectious diseases, and treatments for genetic and protein defect diseases. Stemirna has established a comprehensive mRNA drug platform that includes a GMP production center and a tumor neoantigen library, along with a clinical cooperation platform for mRNA drug development. With more than a dozen independently-developed projects, Stemirna aims to harness the potential of RNA science to provide safe and effective therapeutic options for patients suffering from various medical conditions.
Developer of small molecular drugs intended for skin diseases. The company focuses on the research and development of innovative drugs for the treatment of androgenetic alopecia, atopic dermatitis/eczema, psoriasis, lupus erythematosus and scars, enabling patients with safe and effective drugs to cure skin diseases.
Immune-Onc Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in Palo Alto, California, founded in 2016. The company specializes in the discovery and development of innovative biologic therapies aimed at treating cancer. Immune-Onc Therapeutics focuses on the tumor microenvironment and immune suppressive pathways, utilizing advanced scientific insights to create novel immuno-oncology products. The company employs a targeted approach to develop first-in-class therapeutic antibodies that disarm immune suppression in tumors, thereby enhancing the immune response against cancer. Through its differentiated pipeline, Immune-Onc Therapeutics aims to provide new treatment options for cancer patients, addressing critical needs in the field of immunology and oncology.
Beijing Julive Technology Co.Ltd. operates an online property valuation platform offering real estate consulting services. The company was founded in 2014 and is based in Beijing, China.
Yisheng Biopharma Co., Ltd. is a biopharmaceutical company focused on the research, development, manufacturing, and marketing of immuno-oncology products and vaccines. Founded in 2002 and headquartered in Beijing, the company operates in China, the United States, Cambodia, and Singapore. Yisheng Biopharma utilizes its novel PIKA immunomodulating technology to enhance immune responses against cancers and infectious diseases. Key products under development include YS-ON-001, an investigational therapy aimed at treating advanced solid tumors, as well as YS-HBV-001, a vaccine for hepatitis B, and a PIKA-based rabies vaccine designed for rapid protection against rabies infection. The company's innovative approach targets multiple immune pathways to improve treatment outcomes.
Teon Therapeutics is a clinical-stage biopharmaceutical company dedicated to improving the lives of cancer patients by developing a focused portfolio of small molecules that inhibit the immunosuppressive and cancer-promoting signaling pathways in the tumor microenvironment. Teon's lead program is an A2BR-specific antagonist that will enter Phase1b trials in 2021.
Clover Biopharmaceuticals is a clinical-stage biotechnology company based in Chengdu, China, focused on discovering and developing innovative biologic therapies for cancer, autoimmune diseases, and infectious diseases. Founded in 2007, the company utilizes its proprietary Trimer-Tag technology platform to create novel biologics that target trimerization-dependent pathways. Clover also offers integrated biopharmaceutical drug manufacturing services and has in-house capabilities for cGMP biomanufacturing, which support the development of select biosimilars. Through its research and development efforts, Clover aims to bring transformative therapies to the market.
Kang Liming Bio is a biomedical technology company that specializes in the development, production and sales of tumor screening diagnostic products such as colorectal cancer fecal non-invasive screening kits.
Triumvira Immunologics is an immunotherapy company focused on developing innovative T cell therapies for cancer treatment. Founded in 2015 and headquartered in Austin, Texas, with research facilities in Hamilton, Canada, the company specializes in chimeric antigen receptor (CAR) and engineered T cell receptor (TCR) therapies. Its proprietary T cell Antigen Coupler (TAC) technology enhances the natural T cell receptor's capabilities and operates independently of the major histocompatibility complex. This unique approach aims to create more effective therapies for a diverse group of patients suffering from both solid and liquid tumors, as well as other diseases. Triumvira's commitment to advancing cancer treatment reflects its mission to improve patient outcomes with safer and more effective therapeutic options.
Sinovent Inc. is a biopharmaceutical company founded in 2016 and headquartered in Suzhou, China, with additional offices in Beijing and Boston. The company focuses on innovation in healthcare by utilizing an advanced biotechnology platform and leveraging extensive management experience and financial resources. Sinovent is dedicated to developing and promoting treatment methods to address global health challenges. Currently, the firm has 12 products in various stages of development, targeting therapeutic areas such as oncology, autoimmune diseases, and infectious diseases. Through its commitment to research and development, Sinovent aims to provide effective medical solutions to improve patient health outcomes.
Hiretual is an AI-driven HR technology company and sourcing tool throughout the recruiting community. The company enables recruiters to source and engage the most relevant people with the right skill, making recruiting smarter, faster, and scalable by pulling candidate data from platforms from the open web and internal database to give users the single talent pool.
Suiyuan Technology is a provider of neural network solutions for artificial intelligence. Its products are deep learning high-end chips developed for cloud data centers, and are positioned on artificial intelligence training platforms. The chip will adopt a unique and innovative architecture independently developed, featuring high computing power, high energy efficiency ratio, programmable, low cost, and support for mainstream machine learning frameworks. It is designed and optimized for cloud AI training.
Apexigen Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody therapeutics for the treatment of cancer. The company develops a pipeline of therapies and product candidates, including APX005M and APX201 for immuno-oncology, APX003/BD0801 and TRK-950 for oncology, APX001/SSS07 for inflammation, and APX003/TK001 for ocular diseases. It also develops APXiMAB platform, which enables discovery of antibodies for novel immune system targets. The company was founded in 2010 and is based in San Carlos, California.
Ansun BioPharma is a clinical-stage biopharmaceutical company focused on the development of unique host-directed anti-viral. The company is committed to developing safe and effective immuno-biologic therapies to treat the most vulnerable patients. Its founders were ingenious virologists and molecular biologists who realized that targeting a virus is difficult due to the virus’s ability to mutate and avoid the treatment. This ability to mutate also enables the virus to evade vaccines. So instead of trying to hit a moving target, they developed an innovative new approach to fight respiratory viruses: they targeted the host instead of the virus.
The company was founded in 2003 and is headquartered in San Diego, California.
Suiyuan Technology is a provider of neural network solutions for artificial intelligence. Its products are deep learning high-end chips developed for cloud data centers, and are positioned on artificial intelligence training platforms. The chip will adopt a unique and innovative architecture independently developed, featuring high computing power, high energy efficiency ratio, programmable, low cost, and support for mainstream machine learning frameworks. It is designed and optimized for cloud AI training.
Horizon Robotics, founded in 2015 and headquartered in Beijing, China, specializes in developing advanced chips for robotics and artificial intelligence applications. The company focuses on providing integrated, open embedded AI solutions that are designed to be high-performance, low-power, and cost-effective. Horizon Robotics aims to enable a wide range of devices, including autonomous vehicles, to operate with enhanced intelligence, facilitating capabilities such as perception, understanding, and decision-making to improve safety and convenience. The company's co-founding team possesses expertise in algorithms, software, hardware, and chip development, supported by a robust research and development team with significant industry experience. Horizon Robotics has garnered considerable investment from prominent venture capital firms and notable investors, positioning itself as a leading player in the global AI startup landscape.
Inspirna is a biopharmaceutical company focused on discovering and developing innovative therapeutic targets and drugs for various cancer subtypes, including melanoma, colorectal cancer, and triple-negative breast cancer. Utilizing a proprietary microRNA-based target discovery platform, Inspirna identifies and validates novel post-transcriptionally regulated targets, leading to the creation of first-in-class therapeutics. The company has developed several promising drug candidates, such as RGX-104, an oral small molecule designed for treating solid tumors, RGX-202, which targets cancer metabolism in gastrointestinal cancers, and RGX-019, a monoclonal antibody aimed at disrupting pathways that promote tumor progression and metastasis. Founded in 2010 and headquartered in New York, Inspirna strives to transform the lives of cancer patients by providing safe and effective therapies for metastatic disease.
Zhaoyou is a B2B ecommerce platform for the petroleum industry. The company provides a transaction platform for the petroleum industry, providing comprehensive fuel trading, logistics, and financial services to its customers, which include some of China’s leading logistics companies.
Tiger Brokers is an online brokerage firm based in Guangdong, China, established in 2014 to serve Chinese investors looking to trade in overseas securities, particularly on U.S. and Hong Kong exchanges. The firm offers a comprehensive trading platform that includes features such as one-click short selling, personal profit and loss analysis, and stock options trading. The app, 'Tiger for US Stocks', has a user-friendly Chinese interface and provides real-time quotes, making it accessible across various operating systems, including iOS, Android, Windows, and Mac OS. In addition to brokerage services, Tiger Brokers also offers value-added services like margin financing, account management, investor education, and customer support, aimed at enhancing the trading experience for its users.
Ansun BioPharma is a clinical-stage biopharmaceutical company focused on the development of unique host-directed anti-viral. The company is committed to developing safe and effective immuno-biologic therapies to treat the most vulnerable patients. Its founders were ingenious virologists and molecular biologists who realized that targeting a virus is difficult due to the virus’s ability to mutate and avoid the treatment. This ability to mutate also enables the virus to evade vaccines. So instead of trying to hit a moving target, they developed an innovative new approach to fight respiratory viruses: they targeted the host instead of the virus.
The company was founded in 2003 and is headquartered in San Diego, California.